Land: Suður-Afríka
Tungumál: enska
Heimild: South African Health Products Regulatory Authority (SAHPRA)
Biotech Laboratories (Pty) Ltd
See ingredients
CAPSULES
EACH CAPSULE CONTAINS FUROSEMIDE 40,0 mg
Registered
1990-01-11
Biotech Laboratories (Pty) Ltd Patient Information Leaflet Furosemide 40 Biotech, capsules Each capsule contains 40 mg furosemide Page 1 of 11 PATIENT INFORMATION LEAFLET SCHEDULING STATUS: FUROSEMIDE 40 BIOTECH, CAPSULE FUROSEMIDE CONTAINS SUGAR (LACTOSE 90 MG PER CAPSULE) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING FUROSEMIDE 40 BIOTECH • Keep this leaflet. You may need to read it again. • If you have further questions, please ask your doctor, pharmacist nurse or other healthcare provider. • Furosemide 40 Biotech has been prescribed for you personally and you should not share your medicine with other people. It may harm them, even if their symptoms are the same as yours. WHAT IS IN THIS LEAFLET 1. What Furosemide 40 Biotech is and what it is used for 2. What you need to know before you take Furosemide 40 Biotech 3. How to take Furosemide 40 Biotech 4. Possible side effects 5. How to store Furosemide 40 Biotech 6. Contents of the pack and other information 1. WHAT FUROSEMIDE 40 BIOTECH IS AND WHAT IT IS USED FOR Furosemide capsules is one of a group of medicines called diuretics (water tablets). Your doctor has prescribed Furosemide 40 Biotech capsules to treat a condition called oedema where there is too much water in your body. This could be due to problems with your heart, lungs, kidneys, liver, blood S3 Biotech Laboratories (Pty) Ltd Patient Information Leaflet Furosemide 40 Biotech, capsules Each capsule contains 40 mg furosemide Page 2 of 11 vessels or high blood pressure. Furosemide 40 Biotech helps your kidneys to get rid of the extra water that is not needed in your body. _ _ 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE FUROSEMIDE 40 BIOTECH DO NOT TAKE FUROSEMIDE 40 BIOTECH IF: • you are allergic (hypersensitive) to furosemide, sulphonamides or any of the other ingredients in Furosemide 40 Biotech capsules (see section 6) • you have elevated levels of urea and other nitrogen compounds in your blood • you have a condition which is characterised by low blood volume (with or without Lestu allt skjalið
Biotech Laboratories (Pty) Ltd Professional Information Furosemide 40 Biotech, capsules Each capsule contains 40 mg furosemide Page 1 of 13 SCHEDULING STATUS S3 1.NAME OF THE MEDICINE Furosemide 40 Biotech (Capsules) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 40 mg furosemide. _Excipient with known effect: _ Each capsule contains 90,0 mg lactose. For full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Capsules Opaque white body/opaque turquoise blue cap, size ‘2’ snap-fit capsule containing white, lump-free powder. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of oedema of cardiac, hepatic or renal origin. In the management of refractory oedema, it may be used in conjunction with other types of diuretics, particularly the potassium-sparing medicines. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION In most cases 40 mg daily will suffice. If no response is obtained, this dose may be increased after 6 Biotech Laboratories (Pty) Ltd Professional Information Furosemide 40 Biotech, capsules Each capsule contains 40 mg furosemide Page 2 of 13 hours to 80 mg and - if necessary - after another 6 hours to 120 mg. Daily doses of more than 120 mg should preferably be distributed over 2 - 3 individual doses. After mobilising the oedema, maintenance therapy is continued i.e., 20 to 40 mg daily. Children generally receive daily oral doses of 1 mg/kg body weight. If necessary, this dose may be increased step by step to a maximum of 3 mg/kg body weight per day. A dose of 120 mg per day should not be exceeded with children. METHOD OF ADMINISTRATION For oral administration. 4.3 CONTRAINDICATIONS Patients who exhibit hypersensitivity to furosemide, sulphonamides, or to any of the excipients as listed in section 6.1. Furosemide 40 Biotech is contraindicated if increasing azotaemia and oliguria occurs during treatment of severe progressive renal disease, anuria, hypokalaemia, hyponatraemia, hypovolaemia with or without hypotension, dehydration - in these cases the medicine should be di Lestu allt skjalið